Extended follow up of high-dose melphalan and autologous stem cell transplantation after vincristine, doxorubicin, dexamethasone induction in amyloid light chain amyloidosis of the prospective phase ii HOVON-41 study by the dutch-belgian co-operative trial group for hematology oncology